Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures

Bone

Volumn 46, Issue 4, 2010, Pages 1100-1107

  Addison, William N ^a   McKee, Marc D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Bone; Inositol hexakisphosphate; Osteoblast; Osteopontin; Phytic acid

Indexed keywords

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; COLLAGEN; INOSITOL; INOSITOL HEXASULFATE; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PHOSPHATE; PHYTIC ACID;

ANIMAL CELL; ARTICLE; BONE MATRIX; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; INHIBITION KINETICS; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SURFACE CHARGE;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; PHYTIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; UP-REGULATION;

EID: 77950534419     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.01.367     Document Type: Article

References (62)

1. Irvine R.F., Schell M.J. Back in the water: the return of the inositol phosphates. Nat. Rev. Mol. Cell. Biol. 2001, 2:327-338.
2. Sasakawa N., Sharif M., Hanley M.R. Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate. Biochem. Pharmacol. 1995, 50:137-146.
3. Raboy V. myo-Inositol-1,2,3,4,5,6-hexakisphosphate. Phytochemistry 2003, 64:1033-1043.
4. Heslop J.P., Irvine R.F., Tashjian A.H., Berridge M.J. Inositol tetrakis- and pentakisphosphates in GH4 cells. J. Exp. Biol. 1985, 119:395-401.
5. Vallejo M., Jackson T., Lightman S., Hanley M.R. Occurrence and extracellular actions of inositol pentakis-and hexakisphosphate in mammalian brain. Nature 1987, 330:656-658.
6. Szwergold B.S., Graham R.A., Brown T.R. Observation of inositol pentakis- and hexakis-phosphates in mammalian tissues by 31P NMR. Biochem. Biophys. Res. Commun. 1987, 149:874-881.
7. Pittet D., Schlegel W., Lew D.P., Monod A., Mayr G.W. Mass changes in inositol tetrakis-and pentakisphosphate isomers induced by chemotactic peptide stimulation in HL-60 cells. J. Biol. Chem. 1989, 264:18489-18493.
8. Bunce C.M., French P.J., Allen P., Mountford J.C., Moor B., Greaves M.F., et al. Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts. Biochem. J. 1993, 289(Pt 3):667-673.
9. Grases F., Simonet B.M., March J.G., Prieto R.M. Inositol hexakisphosphate in urine: the relationship between oral intake and urinary excretion. BJU Int. 2000, 85:138-142.
10. Grases F., Isern B., Perello J., Sanchis P., Prieto R.M., Costa-Bauza A. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans. Pharmazie 2006, 61:652.
11. Grases F., Simonet B.M., Vucenik I., Prieto R.M., Costa-Bauza A., March J.G., et al. Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans. Biofactors 2001, 15:53-61.
12. Grases F., Simonet B.M., Vucenik I., Perello J., Prieto R.M., Shamsuddin A.M. Effects of exogenous inositol hexakisphosphate (InsP(6)) on the levels of InsP(6) and of inositol trisphosphate (InsP(3)) in malignant cells, tissues and biological fluids. Life Sci. 2002, 71:1535-1546.
13. Irvine R.F. Inositide evolution-towards turtle domination?. J. Physiol. 2005, 566:295-300.
14. Shears S.B. Assessing the omnipotence of inositol hexakisphosphate. Cell. Signal. 2001, 13:151-158.
15. Grases F., Sanchis P., Costa-Bauza A., Bonnin O., Isern B., Perello J., et al. Phytate inhibits bovine pericardium calcification in vitro. Cardiovasc. Pathol. 2008, 17:139-145.
16. Grases F., Sanchis P., Perello J., Isern B., Prieto R.M., Fernandez-Palomeque C., et al. Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats. Circ. J. 2007, 71:1152-1156.
17. Magrill D.S. Phytate inhibition of enamel hardening by mineralizing solutions. J. Dent. Res. 1973, 52:1342.
18. Grases F., Isern B., Sanchis P., Perello J., Torres J.J., Costa-Bauza A. Phytate acts as an inhibitor in formation of renal calculi. Front. Biosci. 2007, 12:2580-2587.
19. Grases F., Garcia-Gonzalez R., Torres J.J., Llobera A. Effects of phytic acid on renal stone formation in rats. Scand. J. Urol. Nephrol. 1998, 32:261-265.
20. Sodek J., Ganss B., McKee M.D. Osteopontin. Crit. Rev. Oral Biol. Med. 2000, 11:279-303.
21. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
22. Luttrell B.M. The biological relevance of the binding of calcium ions by inositol phosphates. J. Biol. Chem. 1993, 268:1521-1524.
23. Torres J., Dominguez S., Cerda M.F., Obal G., Mederos A., Irvine R.F., et al. Solution behaviour of myo-inositol hexakisphosphate in the presence of multivalent cations. Prediction of a neutral pentamagnesium species under cytosolic/nuclear conditions. J. Inorg. Biochem. 2005, 99:828-840.
24. Qin C., Baba O., Butler W.T. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit. Rev. Oral Biol. Med. 2004, 15:126-136.
25. Gericke A., Qin C., Spevak L., Fujimoto Y., Butler W.T., Sorensen E.S., et al. Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif. Tissue Int. 2005, 77:45-54.
26. Christensen B., Nielsen M.S., Haselmann K.F., Petersen T.E., Sorensen E.S. Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem. J. 2005, 390:285-292.
27. Sorensen E.S., Hojrup P., Petersen T.E. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci. 1995, 4:2040-2049.
28. Letcher A.J., Schell M.J., Irvine R.F. Do mammals make all their own inositol hexakisphosphate?. Biochem. J. 2008, 416:263-270.
29. Grases F., Simonet B.M., Prieto R.M., March J.G. Phytate levels in diverse rat tissues: influence of dietary phytate. Br. J. Nutr. 2001, 86:225-231.
30. Grases F., Simonet B.M., Prieto R.M., March J.G. Variation of InsP(4),InsP(5) and InsP(6) levels in tissues and biological fluids depending on dietary phytate. J. Nutr. Biochem. 2001, 12:595-601.
31. Curhan G.C., Willett W.C., Knight E.L., Stampfer M.J. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch. Intern. Med. 2004, 164:885-891.
32. Magrill D.S. Micro determination of phytate in solution or bound to hydroxyapatite. Anal. Biochem. 1972, 49:522-526.
33. Grases F., Ramis M., Costa-Bauza A. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Comparison with the action of other polyphosphates. Urol. Res. 2000, 28:136-140.
34. Grases F., Sanchis P., Perello J., Isern B., Prieto R.M., Fernandez-Palomeque C., et al. Phytate (myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front. Biosci. 2006, 11:136-142.
35. Boskey A.L., Spevak L., Paschalis E., Doty S.B., McKee M.D. Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif. Tissue Int. 2002, 71:145-154.
36. Wang D., Christensen K., Chawla K., Xiao G., Krebsbach P.H., Franceschi R.T. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J. Bone Miner. Res. 1999, 14:893-903.
37. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 1983, 96:191-198.
38. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89:271-277.
39. Tullberg-Reinert H., Jundt G. In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem. Cell. Biol. 1999, 112:271-276.
40. Saito Y., Yoshizawa T., Takizawa F., Ikegame M., Ishibashi O., Okuda K., et al. A cell line with characteristics of the periodontal ligament fibroblasts is negatively regulated for mineralization and Runx2/Cbfa1/Osf2 activity, part of which can be overcome by bone morphogenetic protein-2. J. Cell Sci. 2002, 115:4191-4200.
41. Ehara A., Ogata K., Imazato S., Ebisu S., Nakano T., Umakoshi Y. Effects of [alpha]-TCP and TetCP on MC3T3-E1 proliferation, differentiation and mineralization. Biomaterials 2003, 24:831-836.
42. Oka H., Miyauchi M., Sakamoto K., Moriwaki S., Niida S., Noguchi K., et al. PGE2 activates cementoclastogenesis by cementoblasts via EP4. J. Dent. Res. 2007, 86:974-979.
43. Foster B.L., Nociti F.H., Swanson E.C., Matsa-Dunn D., Berry J.E., Cupp C.J., et al. Regulation of cementoblast gene expression by inorganic phosphate in vitro. Calcif. Tissue Int. 2006, 78:103-112.
44. Johnson K., Moffa A., Chen Y., Pritzker K., Goding J., Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J. Bone Miner. Res. 1999, 14:883-892.
45. Beck G.R., Knecht N. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J. Biol. Chem. 2003, 278:41921-41929.
46. Addison W.N., Azari F., Sorensen E.S., Kaartinen M.T., McKee M.D. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J. Biol. Chem. 2007, 282:15872-15883.
47. Beck G.R., Zerler B., Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc. Natl. Acad. Sci. 2000, 97:8352-8357.
48. Efanov A.M., Zaitsev S.V., Berggren P.O. Inositol hexakisphosphate stimulates non-Ca2+-mediated and primes Ca2+-mediated exocytosis of insulin by activation of protein kinase C. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4435-4439.
49. Irvine R.F. 20 years of Ins(1,4,5)P3, and 40 years before. Nat. Rev. Mol. Cell. Biol. 2003, 4:586-590.
50. Grases F., Sanchis P., Perello J., Isern B., Prieto R.M., Fernandez-Palomeque C., et al. Phytate reduces age-related cardiovascular calcification. Front. Biosci. 2008, 13:7115-7122.
51. Gomes B.C., Kaufman H.W., Bloom J.R., Navon J., Wilkens T.J., Rifkin R.A. Inhibitory effect of inositol phosphates on parathyroid hormone-induced bone resorption in organ cultures. J. Dent. Res. 1984, 63:890-893.
52. Magrill D.S. The reduction of the solubility of hydroxyapatite in acid by adsorption of phytate from solution. Arch. Oral Biol. 1973, 18:591-600.
53. Shamsuddin A.M., Vucenik I., Cole K.E. IP6: a novel anti-cancer agent. Life Sci. 1997, 61:343-354.
54. Ferry S., Matsuda M., Yoshida H., Hirata M. Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway. Carcinogenesis 2002, 23:2031-2041.
55. Sakamoto K., Vucenik I., Shamsuddin A.M. [3H]Phytic acid (inositol hexaphosphate) is absorbed and distributed to various tissues in rats. J. Nutr. 1993, 123:713-720.
56. Boitano S., Dirksen E.R., Sanderson M.J. Intercellular propagation of calcium waves mediated by inositol trisphosphate. Science 1992, 258:292-295.
57. Torres-Quintana M.A., Lecolle S., Septier D., Palmier B., Rani S., MacDougall M., et al. Inositol hexasulphate, a casein kinase inhibitor, alters enamel formation in cultured embryonic mouse tooth germs. J. Dent. Res. 2000, 79:1794-1801.
58. Septier D., Torres-Quintana M.A., Menashi S., George A., Goldberg M. Inositol hexasulphate, a casein kinase inhibitor, alters the distribution of dentin matrix protein 1 in cultured embryonic mouse tooth germs. Eur. J. Oral Sci. 2001, 109:198-203.
59. Lasa M., Chang P.L., Prince C.W., Pinna L.A. Phosphorylation of osteopontin by Golgi apparatus casein kinase. Biochem. Biophys. Res. Commun. 1997, 240:602-605.
60. Zhu X., Luo C., Ferrier J.M., Sodek J. Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro. Biochem. J. 1997, 323(Pt 3):637-643.
61. Shamsuddin A.M. Metabolism and cellular functions of IP6: a review. Anticancer Res. 1999, 19:3733-3736.
62. Vucenik I., Shamsuddin A.M. Protection against cancer by dietary IP6 and inositol. Nutr. Cancer 2006, 55:109-125.